METHODS OF REDOSING GENE THERAPY VECTORS.
VE6142020000080SUndetermined Publication Date: 2022-02-17BIOMARIN PHARMACEUTICAL INC
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- VE · VE
- Patent Type
- Designs
- Current Assignee / Owner
- BIOMARIN PHARMACEUTICAL INC
- Filing Date
- 2020-05-14
- Publication Date
- 2022-02-17
Need to check novelty before this filing date? Find Prior Art
Description
This description refers, in general, to methods for readministering, or redosing, a subject who has undergone a first gene therapy regimen with a second or subsequent administration of a gene therapy regimen, wherein the first gene therapy vector and the second gene therapy vector comprise different AAV capsids but carry a transgene or polynucleotide useful for treating the same disease or disorder.